Source link : https://www.newshealth.biz/health-news/diversity-action-plans-for-clinical-trials-evaluating-fdas-draft-guidance/
Lazarus is an adjunct professor of psychiatry. Jernigan is chief operating officer of a service provider for participants in clinical trials. The FDA is intent on improving the enrollment of participants — also known as “subjects” — from underrepresented populations in clinical studies for drugs and devices. The FDA’s initiative is not unlike the attempts […]
Author : News Health
Publish date : 2024-09-06 14:54:01
Copyright for syndicated content belongs to the linked Source.